Pharmafile Logo

How to elevate your communications testing with AI powered insights and analytics

Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers

Pharmaceutical companies strive to develop the most effective communication assets for their brands in order to maximise their impact. The challenge though is in identifying the messages and concepts that will have the greatest impact and influence with customers.

While there is now an appreciation of the subconscious behavioural biases that influence how we respond to marketing, many pharmaceutical companies are still developing and testing the majority of their communication campaigns based on more traditional insight gathering.

At Research Partnership, we have developed a behavioural science-led framework incorporating new AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers. watch this webcast to learn about the various components of this new approach and how each of them offered complementary benefits for a recent client who was looking to evaluate their creative concepts.

What you will learn

  • How innovative new technologies can complement traditional research techniques to provide a truer, multi-dimensional picture of how marketing communications perform with the target audience
  • How a new, behavioural science-led approach to communications research can take into account both instinctive and considered thinking as well as other behavioural biases to provide a more holistic evaluation of marketing materials
  • How to make use of AI, facial analysis and implicit response techniques to gain a 360-degree view of communications performance and how this can overcome the limitations of conducting market research remotely in a post-pandemic era

Watch the webcast

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high...

Event: EULAR Annual European Congress of Rheumatology 2016

We are delighted to be attending the EULAR Annual European Congress of Rheumatology in June. Representing Research Partnership is Business Development Manager, Fara Mboge. He will be on hand to...

Forever Angels achievements and development plan for 2016

Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

The Opportunity for Women’s Health in Emerging Markets

Published in eyeforpharma April 2016 by Rachel Howard

Video: Storytelling in healthcare market research

Within the pharmaceutical industry, there is an increasing need for market research teams to share the insights with their key internal stakeholders, from marketing and brand managers to sales reps...

Promotions and new appointments across our global offices

Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices

Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?

In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy...

Webcast: Understanding the Chronic Disease Patient Journey in Emerging Markets

In emerging markets where primary care systems do not exist, the patient is the only constant in the journey

Living with Crohn’s Report

Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?

Infographic: Research Partnership

Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.